122 results
8-K
EX-10.2
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
equal to $31,397, subject to lawful deductions, to compensate you for the pro-rated Annual Bonus for the year ending December 31, 2024, with such net
8-K
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
of $429,000, and have an initial target bonus opportunity equal to 35% of his base salary. During the term of employment, Mr. Elder’s base salary … and target bonus opportunity is subject to increase (but not decrease) at the discretion of the Board and he will also be eligible to participate
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
base salary, as may be in effect from time to time, is referred to herein as “Base Salary.”
3.2. Annual Bonus. During the Term of Employment … , the Executive shall be eligible to earn an annual performance bonus based on the achievement of the performance goals established by the Board or a committee
8-K
EX-10.2
c9b1cl 3x0hnn
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
1a2ix00rul
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
s4o2 tsgokwie0j0ritc
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.3
xg4wtp6
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
pshcmm
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.1
b4ifyecy1
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K
qupqe 3yhqgmbow2jg
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
9lx2lbop
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
avbdcya
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
425
EX-10.1
q9er4yajg48cav6tlza
19 May 23
Business combination disclosure
4:31pm